Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 8/20 | 0.36 |
| ▸ | PDE4D | Q08499 | 4/20 | 0.35 |
| ▸ | PDE4A | P27815 | 3/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.35 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.35 |
| ▸ | ACACA | Q13085 | 6/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18909798 | 0.87 | PDE4D (0.45) | ACACBPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL30660886 | 0.79 | ACACB (0.37) | ACACBACACA | |
| SCHEMBL19361575 | 0.78 | ACACB (0.44) | ACACBACACA | |
| SCHEMBL18907643 | 0.77 | ACACB (0.50) | ACACBPDE4DPDE4APDE4BPDE4C | |
| SCHEMBL19361571 | 0.73 | POLB (0.41) | TDP1 | |
| SCHEMBL28687158 | 0.73 | ACACA (0.40) | ACACBACACACYP1A2 | |
| SCHEMBL24404186 | 0.73 | ACACA (0.40) | ACACBACACACYP1A2 | |
| SCHEMBL28693469 | 0.73 | ACACA (0.40) | ACACBACACACYP1A2 | |
| SCHEMBL24404210 | 0.73 | ACACA (0.40) | ACACBACACACYP1A2 | |
| SCHEMBL19369284 | 0.71 | LMNA (0.37) | ACACBACACATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3904357-A1 | SPIRO COMPOUND AND MEDICAL USES THEREOF | The National Institutes of Pharmaceutical R&D Co., Ltd (CN) | 2021-11-03 | — | — | EP | disclosed |